Nanostics Company

Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.
Technology:
Canada
Industry:
Reproductive Health & Contraception
Headquarters:
Edmonton, Alberta, Canada
Founded Date:
2017-01-01
Employees Number:
11-50
Investors Number:
1
Total Funding:
$2,231,479
Last Funding Date:
2017-11-15
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership